Farther Finance Advisors LLC lessened its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 7.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 38,770 shares of the company's stock after selling 3,235 shares during the period. Farther Finance Advisors LLC's holdings in Colgate-Palmolive were worth $3,525,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. Kohmann Bosshard Financial Services LLC acquired a new position in Colgate-Palmolive in the fourth quarter worth about $26,000. Centricity Wealth Management LLC acquired a new position in Colgate-Palmolive in the fourth quarter worth about $27,000. Union Bancaire Privee UBP SA acquired a new position in Colgate-Palmolive in the fourth quarter worth about $32,000. Briaud Financial Planning Inc acquired a new stake in shares of Colgate-Palmolive during the fourth quarter worth approximately $32,000. Finally, OFI Invest Asset Management acquired a new stake in shares of Colgate-Palmolive during the fourth quarter worth approximately $36,000. Institutional investors and hedge funds own 80.41% of the company's stock.
Wall Street Analyst Weigh In
Several research firms have recently weighed in on CL. UBS Group dropped their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating for the company in a report on Monday, February 3rd. Piper Sandler dropped their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a report on Monday, January 6th. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $101.00 price objective on shares of Colgate-Palmolive in a report on Wednesday, January 29th. Stifel Nicolaus dropped their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating for the company in a report on Monday, February 3rd. Finally, Wells Fargo & Company dropped their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $101.61.
Check Out Our Latest Research Report on Colgate-Palmolive
Colgate-Palmolive Price Performance
Shares of CL stock opened at $90.71 on Thursday. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30. The stock has a market cap of $73.61 billion, a PE ratio of 25.77, a PEG ratio of 4.20 and a beta of 0.40. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The firm's 50 day moving average price is $89.03 and its two-hundred day moving average price is $94.96.
Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the previous year, the firm earned $0.87 EPS. As a group, analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.
Colgate-Palmolive Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.